Cargando…
A Randomized Controlled Pilot Trial to Test the Efficacy of Intranasal Chlorpheniramine Maleate With Xylitol for the Treatment of Allergic Rhinitis
The prevalence of allergic rhinitis (AR), including symptoms of sneezing, nasal itching, airflow obstruction, and nasal discharge caused by histamine and immunoglobulin E (IgE)-mediated reactions, is ~30% in the U.S. Recent studies seem to suggest that the allergic inflammatory processes in AR may b...
Autores principales: | Sanchez-Gonzalez, Marcos, Rizvi, Syed A, Torres, Joselit, Ferrer, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010914/ https://www.ncbi.nlm.nih.gov/pubmed/33816038 http://dx.doi.org/10.7759/cureus.14206 |
Ejemplares similares
-
Allergic contact dermatitis following drug rash due to chlorpheniramine maleate
por: Shikino, Kiyoshi, et al.
Publicado: (2017) -
Anaphylaxis to Chlorpheniramine Maleate and Literature Review
por: Choi, Yong Won, et al.
Publicado: (2019) -
In Vitro Virucidal Effect of Intranasally Delivered Chlorpheniramine Maleate Compound Against Severe Acute Respiratory Syndrome Coronavirus 2
por: Westover, Jonna B, et al.
Publicado: (2020) -
The Impact of Allergic Rhinitis on Asthma and Its Effect on the Quality of Life of Asthmatic Patients
por: Banjar, Shaima A, et al.
Publicado: (2023) -
Intranasal Xylitol for the Treatment of COVID-19 in the Outpatient Setting: A Pilot Study
por: Soler, Evangelina, et al.
Publicado: (2022)